u 74389f has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kroupis, C; Lagiou, M; Papalois, A; Perlikos, F; Rizou, T; Toumpoulis, IK | 1 |
| Frank, L; McLaughlin, GE | 1 |
2 other study(ies) available for u 74389f and Chronic Lung Injury
| Article | Year |
|---|---|
Lazaroid (U-74389G) ameliorates lung injury due to lipid peroxidation and nitric oxide synthase-dependent reactive oxygen species generation caused by remote systematic ischemia-reperfusion following thoracoabdominal aortic occlusion.
Topics: Animals; Antioxidants; Aorta, Thoracic; Arterial Occlusive Diseases; Disease Models, Animal; Lipid Peroxidation; Lung Injury; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pregnatrienes; Reactive Oxygen Species; Reperfusion Injury; Swine | 2018 |
Protection against acute and chronic hyperoxic inhibition of neonatal rat lung development with the 21-aminosteroid drug U74389F.
Topics: Animals; Animals, Newborn; Antioxidants; Elastin; Female; Free Radicals; Lipid Peroxidation; Lung; Lung Injury; Male; Oxygen; Pregnatrienes; Rats; Rats, Sprague-Dawley | 1993 |